Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Change in Acquisitions & Divestments: 2023-2024

Historic Change in Acquisitions & Divestments for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $745.4 million.

  • CG Oncology's Change in Acquisitions & Divestments rose 24.92% to $251.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $850.1 million, marking a year-over-year increase of 13.76%. This contributed to the annual value of $745.4 million for FY2024, which is 88.04% up from last year.
  • Per CG Oncology's latest filing, its Change in Acquisitions & Divestments stood at $745.4 million for FY2024, which was up 88.04% from $396.4 million recorded in FY2023.
  • In the past 5 years, CG Oncology's Change in Acquisitions & Divestments registered a high of $745.4 million during FY2024, and its lowest value of $396.4 million during FY2023.
  • Moreover, its 2-year median value for Change in Acquisitions & Divestments was $570.9 million (2023), whereas its average is $570.9 million.
  • Data for CG Oncology's Change in Acquisitions & Divestments shows a peak YoY spiked of 88.04% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Change in Acquisitions & Divestments stood at $396.4 million in 2023, then spiked by 88.04% to $745.4 million in 2024.